595 related articles for article (PubMed ID: 16195699)
21. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
Shah K; Tang Y; Breakefield X; Weissleder R
Oncogene; 2003 Oct; 22(44):6865-72. PubMed ID: 14534533
[TBL] [Abstract][Full Text] [Related]
22. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F
Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383
[TBL] [Abstract][Full Text] [Related]
23. AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.
Mohr A; Henderson G; Dudus L; Herr I; Kuerschner T; Debatin KM; Weiher H; Fisher KJ; Zwacka RM
Gene Ther; 2004 Mar; 11(6):534-43. PubMed ID: 14999225
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.
VanOosten RL; Earel JK; Griffith TS
Cancer Gene Ther; 2006 Jun; 13(6):628-32. PubMed ID: 16456549
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect.
Seol JY; Park KH; Hwang CI; Park WY; Yoo CG; Kim YW; Han SK; Shim YS; Lee CT
Cancer Gene Ther; 2003 Jul; 10(7):540-8. PubMed ID: 12833134
[TBL] [Abstract][Full Text] [Related]
26. [Action of apoptosis-induced ligand gene in relation to tumor necrosis factor on human colon cancer cell line HT29].
He C; Hu X; Xu X; Fang B
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):133-6. PubMed ID: 12015033
[TBL] [Abstract][Full Text] [Related]
27. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.
Voelkel-Johnson C; King DL; Norris JS
Cancer Gene Ther; 2002 Feb; 9(2):164-72. PubMed ID: 11857034
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
Shi J; Zheng D; Liu Y; Sham MH; Tam P; Farzaneh F; Xu R
Cancer Res; 2005 Mar; 65(5):1687-92. PubMed ID: 15753363
[TBL] [Abstract][Full Text] [Related]
31. Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts.
Vanoosten RL; Moore JM; Ludwig AT; Griffith TS
Mol Ther; 2005 Apr; 11(4):542-52. PubMed ID: 15771957
[TBL] [Abstract][Full Text] [Related]
32. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis.
Shah K; Tung CH; Breakefield XO; Weissleder R
Mol Ther; 2005 Jun; 11(6):926-31. PubMed ID: 15922963
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated gene transfer of caspase-8 sensitizes human adenocarcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand.
Yasui H; Adachi M; Hamada H; Imai K
Int J Oncol; 2005 Feb; 26(2):537-44. PubMed ID: 15645141
[TBL] [Abstract][Full Text] [Related]
34. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
[TBL] [Abstract][Full Text] [Related]
35. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
36. [The effect of TNF-related apoptosis-inducing ligand on in vivo graft survival after ex vivo adenovirus-mediated gene transfer to cornea].
Guo P; Xie LX; Shi WY; Li XX
Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):19-23. PubMed ID: 12760808
[TBL] [Abstract][Full Text] [Related]
37. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of TRAIL recombinant adenovirus in human malignant glioma cells.
Kim KU; Seo SY; Heo KY; Yoo YH; Kim HJ; Lee HS; Choi SS; Hwang TH; Lee HJ
J Korean Med Sci; 2005 Dec; 20(6):1046-52. PubMed ID: 16361820
[TBL] [Abstract][Full Text] [Related]
39. Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.
Malecaze F; Decha A; Serre B; Penary M; Duboue M; Berg D; Levade T; Lubsen NH; Kremer EJ; Couderc B
Gene Ther; 2006 Mar; 13(5):440-8. PubMed ID: 16251995
[TBL] [Abstract][Full Text] [Related]
40. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.
Fulda S; Wick W; Weller M; Debatin KM
Nat Med; 2002 Aug; 8(8):808-15. PubMed ID: 12118245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
